Medicare Enrolled
Dr. Milind Karve, MD
Cardiovascular Disease · Lansing, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Karve from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Karve?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Karve
Dr. Milind Karve is a cardiovascular disease specialist in Lansing, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Karve performed 4,475 Medicare services across 2,143 unique beneficiaries.
Between the years covered by Open Payments, Dr. Karve received a total of $37,730 from 59 pharmaceutical and/or device companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Karve is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in MI
$37,730 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,475
Medicare services
Top 6% in MI for cardiovascular disease
2,143
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~224 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
742 | $36 | $105 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
656 | $33 | $126 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
623 | $87 | $165 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
379 | $10 | $51 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
304 | $48 | $116 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
184 | $42 | $85 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
165 | $30 | $70 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
157 | $64 | $127 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
109 | $101 | $757 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
92 | $140 | $462 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
90 | $20 | $60 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
88 | $60 | $173 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
78 | $94 | $169 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
67 | $133 | $326 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
66 | $62 | $119 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
62 | $36 | $60 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
59 | $44 | $113 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
59 | $56 | $184 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
55 | $313 | $1,045 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
42 | $9 | $15 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
41 | $142 | $452 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
34 | $39 | $59 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
32 | $7 | $17 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
28 | $18 | $51 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
24 | $8 | $15 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
22 | $72 | $500 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
22 | $5 | $26 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
21 | $13 | $43 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
18 | $410 | $920 |
| Cardiac catheterization | 17 | $192 | $439 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $111 | $247 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $96 | $206 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
15 | $62 | $111 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
14 | $61 | $131 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
14 | $99 | $525 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
14 | $175 | $386 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
13 | $16 | $41 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
13 | $11 | $31 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
12 | $20 | $27 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
11 | $48 | $83 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.5% high complexity
11.4% medium
84.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$37,730
Total received (2018-2024)
Avg $5,390/year across 7 years
Top 9% in MI for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
698
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,294 (69.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,609 (25.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,827 (4.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,933
2023
$3,179
2022
$5,441
2021
$2,366
2020
$5,370
2019
$5,439
2018
$12,003
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$727
ShockWave Medical, Inc
$665
Novartis Pharmaceuticals Corporation
$317
Abbott Laboratories
$263
Boston Scientific Corporation
$232
E.R. Squibb & Sons, L.L.C.
$188
Boehringer Ingelheim Pharmaceuticals, Inc.
$175
Edwards Lifesciences Corporation
$150
ABIOMED
$144
Merck Sharp & Dohme LLC
$97
CARDIVA MEDICAL, INC.
$93
PFIZER INC.
$91
Tactile Systems Technology Inc
$88
Bard Peripheral Vascular, Inc.
$86
Amgen Inc.
$76
Kiniksa Pharmaceuticals International, plc
$68
Lexicon Pharmaceuticals, Inc.
$67
Novo Nordisk Inc
$65
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$64
Philips North America LLC
$62
Actelion Pharmaceuticals US, Inc.
$55
AstraZeneca Pharmaceuticals LP
$42
Chiesi USA, Inc.
$34
Baxter Healthcare
$32
Impulse Dynamics (USA) Inc.
$18
Janssen Pharmaceuticals, Inc
$18
Esperion Therapeutics, Inc.
$14
Top 3 companies account for 43.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$7,513
AstraZeneca Pharmaceuticals LP
$3,630
Medtronic, Inc.
$3,374
Boston Scientific Corporation
$3,305
AngioDynamics, Inc.
$2,675
Medtronic Vascular, Inc.
$1,951
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,477
BOSTON SCIENTIFIC CORPORATION
$1,439
ABIOMED
$1,367
ShockWave Medical, Inc
$1,277
Abbott Laboratories
$1,129
ARALEZ PHARMACEUTICALS US INC.
$1,125
Janssen Pharmaceuticals, Inc
$749
E.R. Squibb & Sons, L.L.C.
$633
Philips Electronics North America Corporation
$621
PFIZER INC.
$537
Amgen Inc.
$506
Edwards Lifesciences Corporation
$412
Shockwave Medical, Inc
$399
Chiesi USA, Inc.
$296
Novo Nordisk Inc
$267
Merck Sharp & Dohme LLC
$246
CARDIVA MEDICAL, INC.
$236
Amarin Pharma Inc.
$232
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$204
Bard Peripheral Vascular, Inc.
$183
SANOFI-AVENTIS U.S. LLC
$174
Kiniksa Pharmaceuticals, Ltd.
$174
Bayer HealthCare Pharmaceuticals Inc.
$148
Teleflex LLC
$122
Silk Road Medical, Inc.
$101
Actelion Pharmaceuticals US, Inc.
$94
Esperion Therapeutics, Inc.
$92
Lexicon Pharmaceuticals, Inc.
$88
Tactile Systems Technology Inc
$88
BARD PERIPHERAL VASCULAR, INC.
$82
Cardiovascular Systems Inc.
$78
Kiniksa Pharmaceuticals International, plc
$68
Bayer Healthcare Pharmaceuticals Inc.
$67
Philips North America LLC
$62
Baxter Healthcare
$61
Impulse Dynamics (USA) Inc.
$58
Lundbeck LLC
$57
ATRICURE, INC.
$44
Bardy Diagnostics, Inc.
$34
United Therapeutics Corporation
$30
Z-Medica, LLC
$22
iRhythm Technologies, Inc.
$22
Inari Medical, Inc.
$20
Siemens Medical Solutions USA, Inc.
$19
Daiichi Sankyo Inc.
$19
Regeneron Healthcare Solutions, Inc.
$18
Maquet Cardiovascular U.S. Sales, L.L.C.
$16
Gilead Sciences, Inc.
$16
Amryt Pharma Holdings Ltd
$16
EKOS Corporation
$15
InfoBionic, Inc
$15
Arbor Pharmaceuticals, Inc.
$14
BSN Medical Inc
$12
Top 3 companies account for 38.5% of all-time payments
Associated products mentioned in payments ›
(6571) Eagle Eye · (7999) SRC Undivided · (8333) IGT D Coronary · (9266) ELCA · (CK4) MCOT · ACCENT · ATRICLIP LAA EXCLUSION SYSTEM · AZURE XT DR MRI SURESCAN · AngioJet Ultra 5000A · Arcalyst · Asahi Fielder coronary guide wire · Azure · BRILINTA · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CLEVIPREX · COBALT DR MRI SURESCAN · COMET · CONFIRM RX · COREVALVE EVOLUT R · CROSSBOSS · CardioMEMS HF System · Cardiva VASCADE MVP VVCS 6-12F · CareLink · Carnation Ambulatory Monitor · Claria MRI · CorPath Imaging System · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Crosser iQ · Diamondback Coronary · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · EKOSONIC · ELCA · ELIQUIS · ELUVIA · ENROUTE Transcarotid Neuroprotection System · ENSOETM · ENTRESTO · ESPRIT · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FIGHTER · FLIXENE · FLOWTRIEVER CATHETER · Flexitouch Plus · GENERAL BALLOONS · GENERAL METALLIC STENTS · GENERAL STRUCTURAL HEART · GENERAL THERAPIES · GENERAL - ANGIOPLASTY · GENERAL - STRUCTURAL HEART · GENERAL ATHERECTOMY · GENERAL STENTS · GENERAL THERAPIES · General - Atherectomy · General - Balloons · General - Therapies · General - Vascular Intervention · GuideLiner V3 Catheter · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · Hi-Torque Floppy guide wire · Hillrom - Cardiac Ambulatory Monitor · IGT Device Undivided · IGT_D FM · INJECTAFER · Impella · Inpefa · JARDIANCE · JETSTREAM · JOT DX · JUXTAPID · KENGREAL · Kerendia · LEQVIO · LINQ II · LOKELMA · LifeVest · MANTA · MICRA · MULTAQ · Micra · Mitra Clip system · MoMe Kardia · NEXLETOL · NORTHERA · OPSUMIT · OPTIMIZER · Optimizer · Ozempic · PRADAXA · PRALUENT · Peripheral Orbital Atherectomy System · QUIKCLOT · ROTABLATOR · ROTAPRO · Ranexa · Repatha · Reveal LINQ · Rybelsus · S · SAMURAI · SAPIEN 3 Ultra RESILIA · SELECTSECURE · SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2+ CORONARY · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · SelectSecure · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2+ Coronary · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripher · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYRX · TYVASO · UPTRAVI · VENOVO · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · Verquvo · WALLSTENT · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WOLVERINE · WOLVERINE CORONARY CUTTING BALLOON · XARELTO · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · ZEPHYR · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for cardiovascular disease in MI.
Geographic Context
Cardiologists within 10 mi
41
Per 100K population
14.5
County median income
$64,354
Nearest hospital
EDWARD W SPARROW HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Karve is a clinical cardiology specialist, with above-average Medicare volume (top 6% in MI), with low-engagement industry engagement in the top 9% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Karve experienced with remote patient monitoring management, 20 min/month?
Based on Medicare claims data, Dr. Karve performed 742 remote patient monitoring management, 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Karve receive payments from pharmaceutical companies?
Yes. Dr. Karve received a total of $37,730 from 59 companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Karve's costs compare to other cardiologists in Lansing?
Dr. Karve's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Karve) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Lansing
Browse cardiologists in Lansing ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MI
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MI
Which MI cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology